These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32126366)

  • 1. Racial variations in lacosamide serum concentrations in adult patients with epilepsy.
    Zutshi D; Yarraguntla K; Mahulikar A; Seraji-Bozorgzad N; Shah AK; Basha MM
    J Neurol Sci; 2020 May; 412():116742. PubMed ID: 32126366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs.
    Neal A; D'Souza W; Hepworth G; Lawn N; Cook M; Nikpour A
    Epilepsy Behav; 2018 Mar; 80():25-32. PubMed ID: 29396359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study.
    Del Bianco C; Placidi F; Liguori C; Mari L; Ulivi M; Ornello R; Pisani A; Mercuri NB; Izzi F
    Epilepsy Behav; 2019 May; 94():178-182. PubMed ID: 30959275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lacosamide serum concentrations in adult patients with epilepsy: the influence of gender, age, dose, and concomitant antiepileptic drugs.
    Markoula S; Teotonio R; Ratnaraj N; Duncan JS; Sander JW; Patsalos PN
    Ther Drug Monit; 2014 Aug; 36(4):494-8. PubMed ID: 24562047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lacosamide therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.
    Contin M; Albani F; Riva R; Candela C; Mohamed S; Baruzzi A
    Ther Drug Monit; 2013 Dec; 35(6):849-52. PubMed ID: 23942540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of the dose and blood concentration of lacosamide in Japanese pediatric patients with epilepsy: A cohort study.
    Ishikawa N; Eguchi Y; Izumo H; Tateishi Y; Tani H; Kobayashi Y; Okada S
    Epilepsy Behav; 2022 Apr; 129():108614. PubMed ID: 35203014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lacosamide tolerability in adult patients with partial-onset seizures: Impact of planned reduction and mechanism of action of concomitant antiepileptic drugs.
    Foldvary-Schaefer N; Fong JS; Morrison S; Wang L; Bena J
    Epilepsy Behav; 2016 Apr; 57(Pt A):155-160. PubMed ID: 26956629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, multicenter, noninterventional study in Taiwan to evaluate the safety and tolerability of lacosamide as adjunctive therapy for epilepsy in clinical practice.
    Wu T; Chuang YC; Huang HC; Lim SN; Hsieh PF; Lee WT; Cheng MY; Tsai MH; Jou SB; Chang CW; Hsieh HY; Du X; Hellot S; McClung C; Hung C
    Epilepsy Behav; 2020 Dec; 113():107464. PubMed ID: 33152580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
    Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
    Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjunctive lacosamide in clinical practice: sodium blockade with a difference?
    Stephen LJ; Kelly K; Parker P; Brodie MJ
    Epilepsy Behav; 2011 Nov; 22(3):499-504. PubMed ID: 21890421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical management of elderly patients with epilepsy; the use of lacosamide in a single center setting.
    Rainesalo S; Mäkinen J; Raitanen J; Peltola J
    Epilepsy Behav; 2017 Oct; 75():86-89. PubMed ID: 28834781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes of perampanel vs. lacosamide in cohorts of consecutive patients with severely refractory epilepsies - A monocentric retrospective analysis of systematically collected data from the German Kork Epilepsy Center.
    Kurth C; Kockelmann E; Steinhoff BJ
    Seizure; 2017 Feb; 45():47-51. PubMed ID: 27915111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The challenges of assessing effectiveness of lacosamide using electronic medical record databases.
    Kalilani L; Halpern R; Seare J; Dedeken P
    Epilepsy Behav; 2018 Aug; 85():195-199. PubMed ID: 30032807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Drug Monitoring of Lacosamide in Norway: Focus on Pharmacokinetic Variability, Efficacy and Tolerability.
    Svendsen T; Brodtkorb E; Baftiu A; Burns ML; Johannessen SI; Johannessen Landmark C
    Neurochem Res; 2017 Jul; 42(7):2077-2083. PubMed ID: 28349359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of CYP2C19 genetic polymorphisms on the pharmacokinetics of lacosamide in Korean patients with epilepsy.
    Ahn SJ; Oh J; Kim DY; Son H; Hwang S; Shin HR; Kim EY; Lee HS; Lee WJ; Moon J; Lee ST; Jung KH; Park KI; Jung KY; Lee S; Yu KS; Chu K; Lee SK
    Epilepsia; 2022 Nov; 63(11):2958-2969. PubMed ID: 36039802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lacosamide as adjunctive therapy in treatment-resistant epilepsy in childhood.
    Gulati P; Cannell P; Ghia T; Bint L; Walsh P; Ghosh S; Nagarajan L
    J Paediatr Child Health; 2015 Aug; 51(8):794-7. PubMed ID: 25683595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in epilepsy treatment: lacosamide pharmacokinetic profile.
    Cawello W; Stockis A; Andreas JO; Dimova S
    Ann N Y Acad Sci; 2014 Nov; 1329():18-32. PubMed ID: 25167889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of lacosamide in children: experience of a tertiary medical care center in Brazil.
    Romão TT; Angelim AIM; Prado HJPD; Goes FV; Pires MEP; Fontana RDS; Pires LC; Fernandes AR; D'Andrea-Meira I
    Arq Neuropsiquiatr; 2022 Nov; 80(11):1090-1096. PubMed ID: 36577407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of drug level concentrations of brivaracetam, lacosamide, and perampanel in care of people with epilepsy.
    Hentschel M; Stoffel-Wagner B; Surges R; von Wrede R; Dolscheid-Pommerich RC
    Epilepsia; 2024 Mar; 65(3):620-629. PubMed ID: 38158709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive effects of lacosamide as adjunctive therapy in refractory epilepsy.
    IJff DM; van Veenendaal TM; Majoie HJ; de Louw AJ; Jansen JF; Aldenkamp AP
    Acta Neurol Scand; 2015 Jun; 131(6):347-54. PubMed ID: 25630655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.